Your browser doesn't support javascript.
loading
Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET).
Takeuchi, Shinji; Yanagitani, Noriko; Seto, Takashi; Hattori, Yoshihiro; Ohashi, Kadoaki; Morise, Masahiro; Matsumoto, Shingo; Yoh, Kiyotaka; Goto, Koichi; Nishio, Makoto; Takahara, Shizuko; Kawakami, Takahiro; Imai, Yasuhito; Yoshimura, Kenichi; Tanimoto, Azusa; Nishiyama, Akihiro; Murayama, Toshinori; Yano, Seiji.
Afiliação
  • Takeuchi S; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Yanagitani N; Cancer Center, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
  • Seto T; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
  • Hattori Y; Department of Thoracic Oncology, National Kyusyu Cancer Center, Minami-Ku, Fukuoka, Japan.
  • Ohashi K; Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan.
  • Morise M; Department of Respiratory Medicine and Allergy, Kita-ku, Okayama University Hospital, Okayama, Japan.
  • Matsumoto S; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Nishio M; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Takahara S; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
  • Kawakami T; Innovative Clinical Research Center (iCREK), Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
  • Imai Y; Innovative Clinical Research Center (iCREK), Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
  • Yoshimura K; Innovative Clinical Research Center (iCREK), Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
  • Tanimoto A; Innovative Clinical Research Center (iCREK), Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
  • Nishiyama A; Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima University, Minami, Hiroshima, Japan.
  • Murayama T; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Yano S; Cancer Center, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
Transl Lung Cancer Res ; 10(1): 314-325, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33569315
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão